These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11069386)

  • 1. Insulin-like growth factor II and androgen receptor expression in the prostate.
    Gnanapragasam VJ; McCahy PJ; Neal DE; Robson CN
    BJU Int; 2000 Oct; 86(6):731-5. PubMed ID: 11069386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens.
    Monti S; Di Silverio F; Lanzara S; Varasano P; Martini C; Tosti-Croce C; Sciarra F
    Steroids; 1998; 63(5-6):362-6. PubMed ID: 9618803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid.
    Marcelli M; Haidacher SJ; Plymate SR; Birnbaum RS
    Endocrinology; 1995 Mar; 136(3):1040-8. PubMed ID: 7532576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M; Sun Z
    Mol Endocrinol; 2005 Feb; 19(2):391-8. PubMed ID: 15514031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.
    Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H
    Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells.
    Grant ES; Ross MB; Ballard S; Naylor A; Habib FK
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3252-7. PubMed ID: 9745438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.
    Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y
    Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.
    Orio F; Térouanne B; Georget V; Lumbroso S; Avances C; Siatka C; Sultan C
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):105-14. PubMed ID: 12573820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.